Drug Detail:Homatropaire (Homatropine ophthalmic [ hoe-ma-troe-peen ])
Drug Class: Mydriatics
Usual Adult Dose for Refraction
Instill 1 to 2 drops into the eye(s) once; may repeat in 5 to 10 minutes if needed
Comments:
- This drug has not been found by the US FDA to be safe and effective and the labeling has not been approved by the US FDA.
Usual Adult Dose for Uveitis
Instill 1 to 2 drops into the eye(s) up to every 3 to 4 hours
Comments:
- This drug has not been found by the US FDA to be safe and effective and the labeling has not been approved by the US FDA.
Usual Pediatric Dose for Refraction
Greater than 3 months: Instill 1 to 2 drops into the eye(s) once; may repeat in 5 to 10 minutes if needed
Comments:
- This drug has not been found by the US FDA to be safe and effective and the labeling has not been approved by the US FDA.
Usual Pediatric Dose for Uveitis
Greater than 3 months: Instill 1 to 2 drops into the eye(s) up to every 3 to 4 hours
Comments:
- This drug has not been found by the US FDA to be safe and effective and the labeling has not been approved by the US FDA.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Safety and efficacy have not been established in patients during the first 3 months of life.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- For topical ophthalmic use only; not for injection.
- Do not allow any solution to get into child's mouth.
- Patients with heavily pigmented irides may require larger doses.
- Wash hands and hands of child after use.
- Compress the lacrimal sac for 2 to 3 minutes after instillation.
Patient advice:
- Avoid touching tip of dropper to any surface as this may cause contamination.
- Transient burning sensation may occur upon instillation.
- Avoid driving or engaging in hazardous activities while pupils are dilated.
- Protect eyes from bright illumination as sensitivity to light can occur.